Plain-English translation of NCT07659119 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Coronary Artery Disease research guide โThis is an observational study โ meaning researchers will follow your medical care without changing your treatment โ that uses a special type of heart imaging called CT-FFR (computed tomography-derived fractional flow reserve) to assess how well blood flows through your heart arteries. The study will track about 3,000 patients with chronic heart disease to see whether this imaging test helps doctors predict which patients are at higher risk for heart problems over the next year.
Many patients with chronic heart disease need imaging to show where arteries are narrowed, but standard imaging doesn't always tell doctors whether a blockage is serious enough to affect blood flow and cause symptoms. This medication aims to fill that gap by showing doctors the functional significance of blockages in real-world clinical practice across China.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will not receive any new treatment or medication โ this is purely an observational study where researchers will monitor your existing care. After your heart imaging scans (CCTA and CT-FFR), you will be followed for one year to track whether you experience any major heart events. Researchers will collect information about your health outcomes, your symptoms, and what treatments your doctors recommend based on your imaging results.
AI-generated summary from trial data ยท Jul 10, 2026 ยท Not medical advice
China